This trial is evaluating whether Cooled Radiofrequency will improve 2 primary outcomes, 5 secondary outcomes, and 7 other outcomes in patients with Low Back Pain. Measurement will happen over the course of 6 months.
This trial requires 188 total participants across 2 different treatment groups
This trial involves 2 different treatments. Cooled Radiofrequency is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Patients will present with low [back pain](https://www.withpower.com/clinical-trials/back-pain). Their complaints are most likely to be associated with movement impairment. Symptoms often relate to spinal disk pathology. Low-back pain can be a significant burden to patients, to carers and to the society as a whole.
In this population presenting for clinical care, LBP is common (>80%) and is strongly correlated with low social status. Although physical and psychological exertion were associated with LBP, only emotional factors were associated with severity. These data will help inform the design and content of treatment programs to address individual factors (physical, psychological, and social) contributing to LBP.
The main treatments are either medical management or chiropractic care. Many people find chiropractic care helpful and preferred. Other treatments tried include medical intervention, occupational therapy, and physical therapy.\n\nMedical use of alternative medicine varies due to lack of research, and is not fully addressed in medical school.\n\nMany medical specialties are concerned with disorders of the nervous system including physical medicine and rehabilitation, neurology, neurosurgery, psychiatry, neurology, physiatry, pain medicine, physiatry, behavioral neurology, functional imaging, critical care.
The prevalence of new back pain cases is stable over time and does not vary greatly from year to year. Results from a recent paper are consistent with the theory that new back pain will develop more often when work demands are higher and that recovery from low back pain will occur slowly but with no long-term morbidity.
The data clearly demonstrate that there is an increased occurrence of low back pain among people at work with a history of low back pain at home. If confirmed by similar studies this may have significant repercussions on the ability of employees to perform or to work, in such cases, in organisations where work is a key facet to the well-being and quality of life of people.
All patients with disabling LBP had some improvement after surgery. Patients with a high level of disability before surgery were less likely to have improvement.
The current research has produced an efficient, quick, low cost method for treatment of low back pain. Additional studies on long-term effects remain necessary, but the results are positive, especially as further improvements in cooling performance and applicability are achieved.
There is a high level of evidence to support the potential benefit of cool radiofrequency (RF) therapy for the treatment of soft tissue pain; however, a small number of randomized controlled trials have been conducted, and a large number of uncontrolled studies have been published in the literature. There has been some evidence suggesting that RF therapy might be effective and safe in the treatment of a broad range of soft tissue and musculoskeletal (including soft tissue pain disorders and musculoskeletal conditions) pain conditions; and there is a high level of evidence suggesting that there may be some benefit to cooler RF therapy in chronic lower back pain. The use of RF therapy deserves further consideration in research trials and in clinical practice.
Patients experienced significant pain relief and improved physical and emotional functioning after 6-month treatment. The improvement persisted over time. CRIQ may be a valuable tool in outcome evaluation for the management of patients with chronic low back pain.
A cooling device of the [HIVEMEDTRAC] type was not associated with adverse effects after a mean cumulative RF energy administration of 42,050J. The cooling device used in this study was not suitable for people but was recommended in another study to provide a cooling medium to the internal RF application region while RF is being administered.
Although there are no clear guidelines, clinicians should consider adding CRF to analgesia options and treatment protocols in patients with persistent non-radicular diskogenic LBP after adjusting medication dosage and frequency.